Chinese Expert Consensus on Immunotherapy for Hepatocellular Carcinoma (2021 Edition)Yu Chi Yang, Jun Zhou, Shusen Zheng et al.|Liver Cancer|2022Cited by 22
RPRD1A drives lenvatinib resistance in hepatocellular carcinoma via the ITGA5-FAK signaling axisXiaoli Yao, Heping Hu, Y X Lin et al.|Molecular Biomedicine|2026Cited by 0